Swedberg, Karl2; Young, James B3; Anand, Inder S3; Cheng, Sunfa3; Desai, Akshay S3; Diaz, Rafael3; Maggioni, Aldo P3; McMurray, John J V3; O'Connor, Christopher3; Pfeffer, Marc A3; Solomon, Scott D3; Sun, Hong Yan4; Tendera, Michal3; van Veldhuisen, Dirk J3; Nielsen, Jens Erik Rokkedal1
1 Medicinsk Afdeling GLO, Amager and Hvidovre Hospital, The Capital Region of Denmark2 Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. firstname.lastname@example.org unknown4 Department of Control and Engineering Design
Patients with systolic heart failure and anemia have worse symptoms, functional capacity, and outcomes than those without anemia. We evaluated the effects of darbepoetin alfa on clinical outcomes in patients with systolic heart failure and anemia.
New England Journal of Medicine, 2013, Vol 368, Issue 13, p. 1210-9